30th ADLM International CPOCT Symposium
DoubleTree Pittsburgh | October 14–16, 2026
DoubleTree Pittsburgh
One Bigelow Square
Pittsburgh, PA 15219
October 14–16, 2026
If you are interested in learning more about sponsorship opportunities at this event, please reach out to Lane Glaster-West or Ana Zelada. There are limited exhibitor spots available, so don’t hesitate to lock in your spot today!
.jpg?h=285&w=285&hash=FB8249A6656C8BED2B963F0140EAB4CC)
Pioneering Diagnostics. A world leader in the field of in vitro diagnostics since 1963, bioMérieux is present in 45 countries and serves more than 160 countries with the support of a large network of distributors. In 2024, revenues reached €4 billion, with over 93% of sales outside of France. bioMérieux provides diagnostic solutions (systems, reagents, software, and services), which determine the source of disease and contamination to improve patient health and ensure consumer safety. Its products are mainly used for diagnosing infectious diseases. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products.
Siemens Healthineers pioneers breakthroughs in healthcare. For everyone. Everywhere. Sustainably. The company is a global provider of healthcare equipment, solutions and services, with activities in more than 180 countries and direct representation in more than 70. The group comprises Siemens Healthineers AG, listed as SHL in Frankfurt, Germany, and its subsidiaries. As a leading medical technology company, Siemens Healthineers is committed to improving access to healthcare for underserved communities worldwide and is striving to overcome the most threatening diseases. The company is principally active in the areas of imaging, diagnostics, cancer care and minimally invasive therapies, augmented by digital technology and artificial intelligence. In fiscal 2025, which ended on September 30, 2025, Siemens Healthineers had approximately 74,000 employees worldwide and generated revenue of around €23.4 billion. Further information is available at siemens-healthineers.com.
Visit clinisys.com for more information..
Eurotrol is a global innovator in quality control solutions for point-of-care and critical care diagnostics. We develop advanced technologies that help laboratories and healthcare professionals achieve greater confidence in patient testing across blood gas, CO-oximetry, coagulation, chemistry and hemoglobin analysis.
Our patented CueSee® technologies simplify quality control, improve workflow efficiency and support reliable clinical decision-making. Together with CueSee® Compare, our complimentary peer comparison platform, we enable laboratories to move beyond traditional QC toward smarter, data-driven quality assurance.
Driven by innovation and committed to excellence, Eurotrol continues to set new standards in quality control for modern healthcare.
Visit abbott.com for more information.
Hospitals go above and beyond to tackle the challenge of providing the highest standards of patient care. Haemonetics delivers quality MedSurg solutions that prioritize patient outcomes to help clinicians confidently provide the best possible care. Backed by over five decades of industry expertise, our technologies are designed to drive procedural effectiveness and elevate the patient experience..
Visit hemosonics.com for more information.
A New Era of Clinical Excellence
Following the merger of Advanced Instruments and Nova Biomedical under the Nova Biomedical name, the company has expanded its global leadership in in vitro diagnostics (IVD), serving healthcare providers in more than 100 countries. Nova Biomedical delivers innovative solutions across clinical chemistry, hematology, microbiology, point-of-care, and critical care, helping laboratories and clinicians improve workflow efficiency and patient outcomes.
StatStrip® Glucose: Hospital Glucose Testing for Every Patient
The StatStrip® Glucose Meter is the only U.S. FDA-cleared bedside glucose testing system for all critically ill patients. Supported by over 200 clinical publications and extensive medication interference testing, it provides lab-quality, interference-free results from capillary, venous, and arterial samples. Advanced features include a cybersecurity-hardened Linux® operating system, wireless charging, NovaNet™ connectivity, and an expanded hematocrit range of 5–75%.
Polymedco partners with healthcare systems, payors, providers, and reference labs to develop best-in-class screening and early detection programs that can help identify life-threatening diseases earlier. We’re proud to offer a portfolio of products with exceptional performance, robust clinical evidence, and user-friendly design.
As rising incidence of chronic diseases, aging populations, and skyrocketing costs strain our healthcare system, Polymedco is committed to making early detection more effective, accessible, and affordable.
QuidelOrtho develops and manufactures intelligent solutions that are transforming data into understanding and action for more people in more places every day, helping spot trends sooner, respond quicker and chart the course ahead with accuracy and confidence. Together, we are advancing diagnostics to power a healthier future. Further information is available at QuidelOrtho.
Leading the way in acute care diagnostics for over 70 years. Radiometer integrates blood gas analyzers, syringes, point-of-care IT, and services. Our mission is to streamline your diagnostic workflows, empowering you to concentrate on what truly matters — caring for your critically ill patients.
TELCOR Point of Care connects more device types and LIS/EMR systems than any other provider. We own no diagnostics or LIS, so devices are selected on needs rather than a vendor’s competing interests. Operator management is centralized and automated, controlling device access, tracking certifications, and maintaining compliance in real time across every point of care testing site. Every call reaches a single, U.S.-based team and each analyst owns the issue through resolution. As a result, we connect 58% of U.S. hospitals, support more than 1 million device connections, and maintain a 97% customer retention rate.
Visit werfen.com for more information.
To learn more about the Arnold & Mabel Beckman Foundation, visit beckman-foundation.org.